Quantum Leap Healthcare Collaborative
search

I-SPY in the News

Widely hailed as the future of phase II drug development, the adaptive I-SPY2 platform trial has set a new benchmark for efficiency, through innovation in trial design and clinical operations.
Close
Close
I-SPY Email List Sign-up

Highlights

Recent Coverage